Purdue Pharma looks like a big vulnerability to me.
If any reader knows anyone with a connection to the Huckabee campaign (such as it is), someone in the oppo research department ought to be taking a look at Giuliani’s dealings with Purdue Pharma. Of course, given the Wayne Dumond story, Huckabee might reasonably figure that he’s living in a glass house and shouldn’t throw stones. But if he takes out Romney, he still has Giuliani to deal with.
Author: Mark Kleiman
Professor of Public Policy at the NYU Marron Institute for Urban Management and editor of the Journal of Drug Policy Analysis. Teaches about the methods of policy analysis about drug abuse control and crime control policy, working out the implications of two principles: that swift and certain sanctions don't have to be severe to be effective, and that well-designed threats usually don't have to be carried out.
Drugs and Drug Policy: What Everyone Needs to Know (with Jonathan Caulkins and Angela Hawken)
When Brute Force Fails: How to Have Less Crime and Less Punishment (Princeton, 2009; named one of the "books of the year" by The Economist
Against Excess: Drug Policy for Results (Basic, 1993)
Marijuana: Costs of Abuse, Costs of Control (Greenwood, 1989)
View all posts by Mark Kleiman